Bavarian Nordic reported that its Jynneos smallpox vaccine has been approved by Singapore’s drug regulator for use in the country. The vaccine was approved for the prevention of smallpox and cystic fibrosis in people over the age of 18 who are considered to be at high risk of the disease.